Zoom partners with Suki to enhance AI clinical documentation for healthcare

Zoom has partnered with Suki, a company specializing in AI-driven clinical documentation, to enhance its telehealth offerings.

Streamlining Documentation Process

The collaboration aims to streamline the documentation process for healthcare organizations, allowing clinicians to focus more on patient care.

Integration of Suki's AI Platform

Suki's AI platform, which automatically drafts clinical notes based on conversations between healthcare providers and patients, will be integrated into Zoom's existing services.

Beneficial for Telehealth and In-Person Consultations

This functionality is beneficial for both telehealth and in-person consultations.

Expanding Reach in the Healthcare Sector

With nearly 140,000 healthcare institutions using Zoom's platform globally, this partnership presents a significant opportunity for Suki to expand its reach in the healthcare sector.

Addressing Workforce Challenges

The healthcare industry is facing challenges such as workforce shortages and physician burnout, and AI-powered tools like Suki's platform can help alleviate these burdens by reducing the time spent on documentation.

Improving Efficiency and Patient Outcomes

The integration of AI into clinical documentation processes is becoming increasingly important as it can automate note-taking and streamline administrative tasks, leading to improved efficiency and patient outcomes.

Potential for Future Partnerships and Advancements

The partnership between Zoom and Suki has the potential to transform how healthcare providers manage documentation, allowing them to dedicate more time to patient care. The ongoing investments in AI technologies indicate a promising future for healthcare innovation, as organizations recognize the value of these tools in addressing workforce challenges and improving operational efficiency.

Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings